Skip to content

ELECTRIC-AI pilot study: The evaluation of patient-reported symptoms in remote monitoring care of ICD patients

ELECTRIC-AI pilot study: The evaluation of patient-reported symptoms in remote monitoring care of ICD patients - ELECTRIC-AI

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON57164
Enrollment
75
Registered
2024-07-15
Start date
2024-12-13
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ICD or CRT-D carriers ICD or CRT-D patients

Interventions

Participants use a mobile application for registering their symptoms. In the background, these symptoms will be linked to ICD data, the standard care will not be adjusted.

Sponsors

Amsterdam UMC
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - Implanted with a Gallant* ICD or CRT-D device - Participation in the remote monitoring program at AUMC - Patients >=18 years old

Exclusion criteria

Exclusion criteria: - Not able to provide written informed consent - Not able to use the Castor Connect application - A life expectancy of less than one year - Insufficient understanding of the Dutch language

Design outcomes

Primary

MeasureTime frame
The main study endpoint is the actionability of the follow-up action corresponding to each remote device and symptom transmission. Second endpoint is the usability, assessed by evaluating the ease of use through a standardized questionnaire (UMUX) and semi-structured interviews (n=5). Moreover, the data collected during this study will be used to develop an automated triage algorithm for remote transmissions.

Secondary

MeasureTime frame
Additional secondary endpoints will contain the results of the EQ-5D, KCCQ-12, and HADS questionnaires and primary outcome measures for a subsequent randomized controlled trial (e.g. non-actionable in-person evaluations, safety endpoint (MACE/SAE), appropriate and inappropriate ICD-therapy, quality of life, anxiety scores, and time to diagnosis of a clinical event).

Countries

Netherlands

Contacts

Public ContactF.D. Raijmakers

Amsterdam UMC

electricai@amsterdamumc.nl020 566 8912

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: May 22, 2026